183 related articles for article (PubMed ID: 38673867)
1. Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis.
Tsai HE; Chen CL; Chang TT; Fu CW; Chen WC; Perez SJLP; Hsiao PW; Tai MH; Li WS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673867
[TBL] [Abstract][Full Text] [Related]
2. A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling.
Chiang CH; Wang CH; Chang HC; More SV; Li WS; Hung WC
J Cell Physiol; 2010 May; 223(2):492-9. PubMed ID: 20112294
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of sulfonate and sulfate analogues of lithocholic acid: A bioisosterism-guided approach towards the discovery of potential sialyltransferase inhibitors for antimetastatic study.
Perez SJLP; Chen CL; Chang TT; Li WS
Bioorg Med Chem Lett; 2024 Jun; 105():129760. PubMed ID: 38641151
[TBL] [Abstract][Full Text] [Related]
4. A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways.
Chen JY; Tang YA; Huang SM; Juan HF; Wu LW; Sun YC; Wang SC; Wu KW; Balraj G; Chang TT; Li WS; Cheng HC; Wang YC
Cancer Res; 2011 Jan; 71(2):473-83. PubMed ID: 21224350
[TBL] [Abstract][Full Text] [Related]
5. Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis.
Fu CW; Tsai HE; Chen WS; Chang TT; Chen CL; Hsiao PW; Li WS
J Med Chem; 2021 Jan; 64(1):527-542. PubMed ID: 33371679
[TBL] [Abstract][Full Text] [Related]
6. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis.
Su ML; Chang TM; Chiang CH; Chang HC; Hou MF; Li WS; Hung WC
PLoS One; 2014; 9(6):e98823. PubMed ID: 24915301
[TBL] [Abstract][Full Text] [Related]
8. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of B- and C-ring-modified lithocholic acid analogues as potential sialyltransferase inhibitors.
Abdu-Allah HH; Chang TT; Li WS
Steroids; 2016 Aug; 112():54-61. PubMed ID: 27154753
[TBL] [Abstract][Full Text] [Related]
10. α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells.
Wen KC; Sung PL; Hsieh SL; Chou YT; Lee OK; Wu CW; Wang PH
Oncotarget; 2017 Apr; 8(17):29013-29027. PubMed ID: 28423672
[TBL] [Abstract][Full Text] [Related]
11. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
12. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.
Ma X; Dong W; Su Z; Zhao L; Miao Y; Li N; Zhou H; Jia L
Cell Death Dis; 2016 Dec; 7(12):e2561. PubMed ID: 28032858
[TBL] [Abstract][Full Text] [Related]
13. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
14. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
15. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.
Hsu CC; Lin TW; Chang WW; Wu CY; Lo WH; Wang PH; Tsai YC
Gynecol Oncol; 2005 Feb; 96(2):415-22. PubMed ID: 15661230
[TBL] [Abstract][Full Text] [Related]
16. Sialyltransferase inhibition and recent advances.
Wang L; Liu Y; Wu L; Sun XL
Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
[TBL] [Abstract][Full Text] [Related]
17. Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.
Britain CM; Holdbrooks AT; Anderson JC; Willey CD; Bellis SL
J Ovarian Res; 2018 Feb; 11(1):12. PubMed ID: 29402301
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
[TBL] [Abstract][Full Text] [Related]
19. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
Li W; Niu Y; Xiong DC; Cao X; Ye XS
J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells.
Lee M; Park JJ; Ko YG; Lee YS
Radiat Oncol; 2012 Mar; 7():47. PubMed ID: 22449099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]